153 related articles for article (PubMed ID: 27537722)
21. Electrocardiographic characteristics in patients with pulmonary sarcoidosis indicating cardiac involvement.
Schuller JL; Olson MD; Zipse MM; Schneider PM; Aleong RG; Wienberger HD; Varosy PD; Sauer WH
J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1243-8. PubMed ID: 21615816
[TBL] [Abstract][Full Text] [Related]
22. Volume overload modulates effects of cardiac resynchronization therapy independently of myocardial reperfusion: results of the RESYNC study.
Gimelli A; Stanislao M; Valle G; Frumento P; Zanco P; Ometto R; Inglese E; Martino G; Startari U; Bertelli P; Marzullo P
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):575-81. PubMed ID: 17667027
[TBL] [Abstract][Full Text] [Related]
23. Assessment of LV systolic dyssynchrony in heart failure beyond a snapshot.
Yu CM; Zhang Q
JACC Cardiovasc Imaging; 2011 May; 4(5):457-9. PubMed ID: 21565731
[No Abstract] [Full Text] [Related]
24. Infliximab for Refractory Cardiac Sarcoidosis.
Harper LJ; McCarthy M; Ribeiro Neto ML; Hachamovitch R; Pearson K; Bonanno B; Shaia J; Brunken R; Joyce E; Culver DA
Am J Cardiol; 2019 Nov; 124(10):1630-1635. PubMed ID: 31500815
[TBL] [Abstract][Full Text] [Related]
25. Ambulatory blood pressure monitoring, 2D-echo and clinical variables relating to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation.
Antonini L; Pasceri V; Mollica C; Ficili S; Poti G; Aquilani S; Santini M; La Rocca S
J Cardiovasc Med (Hagerstown); 2011 May; 12(5):334-9. PubMed ID: 21487343
[TBL] [Abstract][Full Text] [Related]
26. Development of pulmonary and cardiac sarcoidosis during etanercept therapy.
Miyagi R; Ideguchi H; Soga T; Yamakawa Y; Otsuki H; Niino H; Shiina T; Ueda A; Ishigatsubo Y
Int J Rheum Dis; 2014 Sep; 17(7):810-2. PubMed ID: 24460777
[No Abstract] [Full Text] [Related]
27. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone.
Yazaki Y; Isobe M; Hiroe M; Morimoto S; Hiramitsu S; Nakano T; Izumi T; Sekiguchi M;
Am J Cardiol; 2001 Nov; 88(9):1006-10. PubMed ID: 11703997
[TBL] [Abstract][Full Text] [Related]
28. Utility of cardiac magnetic resonance in assessing right-sided heart failure in sarcoidosis.
Lønborg J; Ward M; Gill A; Grieve SM; Figtree GA
BMC Med Imaging; 2013 Jan; 13():2. PubMed ID: 23311586
[TBL] [Abstract][Full Text] [Related]
29. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis.
Matoh F; Satoh H; Shiraki K; Odagiri K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Cardiol; 2008 Jun; 51(3):179-88. PubMed ID: 18522793
[TBL] [Abstract][Full Text] [Related]
30. Stroke volume paradox in heart failure: mathematical validation.
Adhyapak SM; Parachuri VR
Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):288-95. PubMed ID: 24585904
[TBL] [Abstract][Full Text] [Related]
31. [Six-minute walk test in sarcoidosis patients with cardiac involvement].
Kowalska A; Puścińska E; Goljan-Geremek A; Czerniawska J; Stokłosa A; Kram M; Tomkowski WZ; Górecka D
Pneumonol Alergol Pol; 2012; 80(5):430-8. PubMed ID: 22926904
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of cardiac sarcoidosis based on clinical suspicion and advanced cardiac imaging: A case report.
Aguilar-Gallardo JS; Arreaza J; Omar A; Lasam G; Contreras JP
Medicine (Baltimore); 2022 Aug; 101(34):e30306. PubMed ID: 36042616
[TBL] [Abstract][Full Text] [Related]
33. Cardiac sarcoidosis. A case with unusual manifestation.
Cepin D; McDonough M; James F
Arch Intern Med; 1983 Jan; 143(1):142-4. PubMed ID: 6849593
[TBL] [Abstract][Full Text] [Related]
34. Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.
Trivieri MG; Spagnolo P; Birnie D; Liu P; Drake W; Kovacic JC; Baughman R; Fayad ZA; Judson MA
J Am Coll Cardiol; 2020 Oct; 76(16):1878-1901. PubMed ID: 33059834
[TBL] [Abstract][Full Text] [Related]
35. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
36. A patient with sarcoidosis and antiphospholipid syndrome.
Carragoso A; Silva JR; Capelo J; Faria B; Gaspar O
Eur J Intern Med; 2008 Dec; 19(8):e80-1. PubMed ID: 19046709
[No Abstract] [Full Text] [Related]
37. Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device.
Segura AM; Radovancevic R; Demirozu ZT; Frazier OH; Buja LM
Cardiovasc Pathol; 2014; 23(1):17-20. PubMed ID: 23928368
[TBL] [Abstract][Full Text] [Related]
38. [Pulmonary and cardiac recurrence of sarcoidosis in a heart transplant recipient].
Strecker T; Zimmermann I; Wiest GH
Dtsch Med Wochenschr; 2007 May; 132(21):1159-62. PubMed ID: 17506010
[TBL] [Abstract][Full Text] [Related]
39. Sickle cell disease, pulmonary hypertension, and sarcoidosis.
Lehmann LH; Riess H; Sturm I
Ann Hematol; 2008 Jul; 87(7):591-2. PubMed ID: 18228021
[No Abstract] [Full Text] [Related]
40. Ventricular tachyarrhythmia due to cardiac sarcoidosis in a child.
Serwer GA; Edwards SB; Benson DW; Anderson PA; Spach M
Pediatrics; 1978 Sep; 62(3):322-5. PubMed ID: 704204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
